Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth.

Autor: Cooke ME; Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA., Knoll SJ; Department of Psychiatry, Massachusetts General Hospital, USA., Streck JM; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA., Potter K; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA., Lamberth E; Department of Psychiatry, Massachusetts General Hospital, USA., Rychik N; Department of Psychiatry, Massachusetts General Hospital, USA., Gilman JM; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA., Evins AE; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA., Schuster RM; Department of Psychiatry, Massachusetts General Hospital, USA; Harvard Medical School, Boston, MA, USA. Electronic address: RSCHUSTER@mgh.harvard.edu.
Jazyk: angličtina
Zdroj: Drug and alcohol dependence [Drug Alcohol Depend] 2024 Mar 01; Vol. 256, pp. 111096. Date of Electronic Publication: 2024 Jan 20.
DOI: 10.1016/j.drugalcdep.2024.111096
Abstrakt: Background: It is important to identify interventions that reduce harm in youth not motivated to change their cannabis use. This study evaluated how short-duration contingency management (CM) impacts cannabis use attitudes and behavior after abstinence incentives are discontinued among non-treatment seeking youth.
Methods: Participants (N=220) were randomized to 4 weeks of abstinence-based CM (CB-Abst; n=126) or monitoring (CB-Mon; n=94). Participants completed self-report and provided biochemical measures of cannabis exposure at baseline, end-of-intervention, and 4-week follow-up. Changes in self-reported cannabis use frequency (days/week; times/week) and biochemically verified creatinine-adjusted 11-nor-9-carboxy-tetrahydrocannabinol concentrations (CN-THCCOOH) were analyzed between groups from baseline to follow-up. In CB-Abst, cannabis use goals at end-of-intervention were described and changes in cannabis use at follow-up were explored by goals and cannabis use disorder (CUD) diagnosis.
Results: There was a group by visit interaction on cannabis use (days: beta=0.93, p=0.005; times: beta=0.71, p<0.001; CN-THCCOOH: beta=0.26, p=0.004), with reductions at follow-up detected only in CB-Abst. Following 4 weeks of abstinence, 68.4% of CB-Abst participants wanted to reduce or abstain from cannabis use following completion of CM. Those in CB-Abst who set end-of-intervention reduction goals and were without CUD had greater decreases in cannabis use frequency at follow-up (Goals*time on days/week: beta=-2.27, p<0.001; CUD*time on times/week: beta=0.48, SE=0.24, t=2.01, p=0.048).
Conclusions: Findings support the utility of brief incentivized abstinence for generating motivation to reduce cannabis use and behavior change even after incentives end. This study supports CM as a potentially viable harm reduction strategy for those not yet ready to quit.
Competing Interests: Declaration of Competing Interest There are no interests to declare.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: